Phase III trial of everolimus in metastatic renal cell carcinoma: Subgroup ... - UroToday
UroToday
To assess the efficacy and safety of everolimus in Japanese patients with metastatic renal cell carcinoma. A subgroup analysis of the pivotal Phase III,